Pharmaceutical compositions including ACE/NEP inhibitors and...

Details Pharmaceutical compositions including ACE/NEP inhibitors and... Pharmaceutical compositions including ACE/NEP inhibitors and...

2005-05-10

2005-05-10

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S466000, C514S562000

Reexamination Certificate

active

06890918

ABSTRACT:
A pharmaceutical composition comprising an inhibitor of angiotensin converting enzyme and neutral endopeptidase, such as sampatrilat, and at least one bioavailability enhancer such as an organic acid, e.g., ascorbic acid. Such a composition has improved systemic bioavailability.

REFERENCES:
patent: 4454125 (1984-06-01), Demopoulos
patent: 4975444 (1990-12-01), Danilewicz et al.
patent: 5897876 (1999-04-01), Rudnic et al.
patent: WO 9965500 (1999-12-01), None
Structure of Sampatrilat, Merck Index Abstract # 8428 (2004).*
EP International Search Report dated Sep. 4, 2002 of PCT/US02/13301.
EP International Search Report dated Sep. 4, 2002.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions including ACE/NEP inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions including ACE/NEP inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions including ACE/NEP inhibitors and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3448922